Pharmacy Society of Wisconsin

Registered Principal Details

Business Or Interest:
Pharmacy, heath care

Lobbying Interests:
Pharmacy, health care

CEO Name:
Christopher Decker
Director of Public Affairs

Contact
DML
Danielle M Laurent
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dlaurent@pswi.org
http://www.pswi.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 15
Assembly Bill 15
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)

Bill Text and History

For
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 96
Assembly Bill 96
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.

Bill Text and History

For
Notification Date
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 203
Assembly Bill 203
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)

Bill Text and History

For
Notification Date
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 311
Assembly Bill 311
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)

Bill Text and History

Other
Notification Date
9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 312
Assembly Bill 312
Relating to: limitations on requiring vaccination against influenza.

Bill Text and History

Against
Notification Date
9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 364
Assembly Bill 364
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)

Bill Text and History

2015 Wisconsin Act 266

Other
Notification Date
10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 427
Assembly Bill 427
Relating to: prescription, dispensing, and delivery of opioid antagonists.

Bill Text and History

2015 Wisconsin Act 115

For
Notification Date
10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 452
Assembly Bill 452
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)

Bill Text and History

Against
Notification Date
12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 841
Assembly Bill 841
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)

Bill Text and History

2015 Wisconsin Act 313

For
Notification Date
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 865
Assembly Bill 865
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)

Bill Text and History

2015 Wisconsin Act 290

For
Notification Date
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 866
Assembly Bill 866
Relating to: prescription refills.

Bill Text and History

2015 Wisconsin Act 291

For
Notification Date
2/9/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 13
Senate Bill 13
Relating to: licensure of home medical oxygen providers, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)

Bill Text and History

2015 Wisconsin Act 3

Other
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 15
Senate Bill 15
Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)

Bill Text and History

2015 Wisconsin Act 43

For
Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 74
Senate Bill 74
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.

Bill Text and History

2015 Wisconsin Act 34

For
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 139
Senate Bill 139
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)

Bill Text and History

2015 Wisconsin Act 35

For
Notification Date
5/19/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 218
Senate Bill 218
Relating to: limitations on requiring vaccination against influenza.

Bill Text and History

Against
Notification Date
9/22/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 238
Senate Bill 238
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)

Bill Text and History

2015 Wisconsin Act 152

Other
Notification Date
9/2/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 268
Senate Bill 268
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)

Bill Text and History

Other
Notification Date
10/12/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 345
Senate Bill 345
Relating to: prescription, dispensing, and delivery of opioid antagonists.

Bill Text and History

For
Notification Date
10/30/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 371
Senate Bill 371
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)

Bill Text and History

Against
Notification Date
12/15/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 708
Senate Bill 708
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)

Bill Text and History

For
Notification Date
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 709
Senate Bill 709
Relating to: prescription refills.

Bill Text and History

For
Notification Date
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 743
Senate Bill 743
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)

Bill Text and History

For
Notification Date
2/24/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Employee Trust Funds
Biennial budget bill treatment of matter relating to
Employee Trust Funds

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Medical Assistance - General
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance - General

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Public Health and Other Programs
Biennial budget bill treatment of matter relating to
Health Services: Public Health and Other Programs

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Safety and Professional Services: Agencywide Provisions
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Agencywide Provisions

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Safety and Professional Services: Program Transfers
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Program Transfers

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Administrative Rulemaking Proceedings

Operation of the Prescription Drug Monitoring Program
Agency Name
Controlled Substances Board (CSB)
Subject
Operation of the Prescription Drug Monitoring Program
Scope Statement
SS 103_15
None
Notification Date
2/1/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Administration of drug products and devices other than vaccines
Agency Name
Pharmacy Examining Board (Phar)
Subject
Administration of drug products and devices other than vaccines
Scope Statement
SS 032_16
For
Notification Date
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Application and examination for pharmacists. SS 089-14
Agency Name
Pharmacy Examining Board (Phar)
Subject
Application and examination for pharmacists. SS 089-14
Scope Statement
Register Number: 705 (9/15/2014)
Other
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Pharmacy practice.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
Other
Notification Date
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Scope Statement
Register Number: 683 (11/15/2012)
Other
Notification Date
7/14/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 1, 8, and 18, relating to definitions, controlled substances and the operation of the Prescription Drug Monitoring Program (PDMP). SS 106-14
Scope Statement
Register Number: 706 (10/15/2014)
Other
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revises Chapters Phar 8 and 18, relating to recording name of person presenting ID and providing data to the prescription drug monitoring program. SS 105-14
Scope Statement
Register Number: 706 (10/15/2014)
Other
Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Pharmacy Administrative Code
Development, drafting or introduction of a proposal relating to
Pharmacy Administrative Code

Action Intended To Affect
Rule (by a state agency)

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

administration of nonvaccine injections
Development, drafting or introduction of a proposal relating to
administration of nonvaccine injections

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

pharmacy benefit managers
Development, drafting or introduction of a proposal relating to
pharmacy benefit managers

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/11/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters relating to pharmacy networks and specialty pharmacy networks
Development, drafting or introduction of a proposal relating to
Matters relating to pharmacy networks and specialty pharmacy networks

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/28/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to pharmacist delivery of services
Development, drafting or introduction of a proposal relating to
Matters related to pharmacist delivery of services

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to medication management and optimization
Development, drafting or introduction of a proposal relating to
Matters related to medication management and optimization

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Medicaid reimbursement and audits
Development, drafting or introduction of a proposal relating to
Medicaid reimbursement and audits

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to pharmacy and pharmacist regulation
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy and pharmacist regulation

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to immunization services and reimbursement
Development, drafting or introduction of a proposal relating to
Matters related to immunization services and reimbursement

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to pharmacy audits
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy audits

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Matters related to pharmacy reimbursement
Development, drafting or introduction of a proposal relating to
Matters related to pharmacy reimbursement

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/3/2015
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
Total Lobbying Expenditures 2015
January - June
$23,178.20
2015
July - December
$45,990.31
2016
January - June
$56,926.04
2016
July - December
$44,596.22
Total $170,690.78
Total Hours Communicating 2015
January - June
217.25
2015
July - December
84.00
2016
January - June
167.70
2016
July - December
115.50
Total 584.45
Total Hours Other 2015
January - June
684.50
2015
July - December
474.00
2016
January - June
520.75
2016
July - December
462.50
Total 2141.75

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: the manufacture and acceptance for sale of products containing microbeads. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2%
2015
July - December
2%
2016
January - June
2016
July - December
Total 1%
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2%
2015
July - December
1%
2016
January - June
2016
July - December
Total < 1%
Relating to: licensure of home medical oxygen providers, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
3%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
Relating to: supply and use of epinephrine auto-injectors by certain authorized entities. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
1%
2016
January - June
2016
July - December
Total < 1%
Relating to: limitations on requiring vaccination against influenza.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
1%
2016
January - June
2016
July - December
Total < 1%
Relating to: prescriptions for controlled substances issued by optometrists and providing an exemption from emergency rule procedures.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2%
2016
January - June
2016
July - December
Total < 1%
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2%
2016
January - June
3%
2016
July - December
Total 1%
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
3%
2016
January - June
2016
July - December
Total < 1%
Relating to: billing the Medical Assistance program for prescription drugs by certain entities. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
3%
2016
January - June
2016
July - December
Total < 1%
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
5%
2016
January - June
2016
July - December
Total 1%
Relating to: prescription, dispensing, and delivery of opioid antagonists.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
5%
2016
January - June
2016
July - December
Total 1%
Relating to: the minimum price of merchandise sold at wholesale or retail. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
5%
2016
January - June
2016
July - December
Total 1%
Relating to: reporting, disclosure, and practitioner review requirements under the prescription drug monitoring program; providing an exemption from emergency rule procedures; and granting rule-making authority. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
10%
2016
January - June
3%
2016
July - December
Total 3%
Relating to: prescription, dispensing, and delivery of opioid antagonists.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
15%
2016
January - June
2016
July - December
Total 3%
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
5%
2016
July - December
Total 1%
Relating to: prescription refills.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
5%
2016
July - December
Total 1%
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
5%
2016
July - December
Total 1%
Relating to: waivers and variances from rules issued by the Pharmacy Examining Board and authorizations for pilot programs. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
15%
2016
July - December
Total 4%
Relating to: the administration by injection of prescribed drugs by pharmacists. (FE)
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
15%
2016
July - December
Total 4%
Relating to: prescription refills.
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
15%
2016
July - December
Total 4%

Budget Bill Subjects

2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
1%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
4%
2015
July - December
2016
January - June
2016
July - December
Total 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
20%
2015
July - December
2016
January - June
2016
July - December
Total 7%

Administrative Rulemaking Proceedings

2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2%
2015
July - December
10%
2016
January - June
2016
July - December
Total 3%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
25%
2016
January - June
3%
2016
July - December
10%
Total 8%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
5%
2016
July - December
15%
Total 4%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
20%
2016
July - December
10%
Total 7%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
2016
July - December
2%
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
2016
July - December
5%
Total 1%

Topics Not Yet Assigned A Bill Or Rule Number

2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
1%
2015
July - December
8%
2016
January - June
2016
July - December
Total 2%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
3%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
3%
2015
July - December
2016
January - June
2016
July - December
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
5%
2015
July - December
2016
January - June
2016
July - December
3%
Total 2%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
50%
2015
July - December
2016
January - June
2016
July - December
7%
Total 18%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2%
2016
January - June
2016
July - December
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
6%
2016
July - December
30%
Total 8%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
2016
July - December
3%
Total < 1%
2015
January - June
2015
July - December
2016
January - June
2016
July - December
Total
2015
January - June
2015
July - December
2016
January - June
2016
July - December
15%
Total 3%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures